Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RAVULIZUMAB-CWVZ: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

53.8%
Female
46.2%
Male

Age Information

The average age of patients reporting adverse events with RAVULIZUMAB-CWVZ is 55.5 years.

Geographic Distribution

The majority of adverse event reports for RAVULIZUMAB-CWVZ originate from US.

Report Summary & Outcomes

10,229
Total Reports
10,229
As Primary/Secondary Suspect
551
Deaths Reported
1,663
Hospitalizations
78
Life-Threatening
24
Disabilities

Reporting Timeline

First adverse event report: 20080101. Most recent report: 20250925. View full timeline →

More About RAVULIZUMAB-CWVZ

RAVULIZUMAB-CWVZ Full Profile Reports by Year Drug Interactions